Results 11 to 20 of about 1,463,514 (262)

Can localised 19F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response? [PDF]

open access: yes, 2010
Background 5-Fluorouracil remains widely used in colorectal cancer treatment more than 40 years after its development. 19F magnetic resonance spectroscopy can be used in vivo to measure 5FU’s half-life and metabolism to cytotoxic fluoronucleotides ...
Griffiths, John R.   +17 more
core   +1 more source

Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases

open access: yes, 2023
Background The role of recurrence-free survival (RFS) as a valid surrogate endpoint for overall survival (OS) in patients who underwent upfront surgery for colorectal liver metastases remains uncertain.
Takeuchi, J   +11 more
core   +1 more source

The effect of routine lymphadenectomy of the hepatic basin on the duration of the liver resection due to colorectal carcinoma metastases [PDF]

open access: yesVojnosanitetski Pregled, 2019
Background/Aim. Today, lymphatic metastases are only a relative contraindication for the surgical treatment of colorectal carcinoma (CRC). The aim of this study was to evaluate the effect of routine lymphadenectomy of the hepatic basin on the duration of
Basarić Dragan D.   +5 more
doaj   +1 more source

The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation [PDF]

open access: yes, 2014
Background: Many deaths from cancer are caused by metastatic burden. Prognosis and survival rates vary, but survival beyond 5 years of patients with untreated metastatic disease in the liver is rare.
Breen, D.   +35 more
core   +1 more source

Surgical treatment of colorectal cancer liver metastases

open access: yesActa Medica Lituanica, 2011
Background. Colorectal cancer is a major health problem. Approximately 25% of the patients present with liver metastases at initial diagnosis and more than 50% develop metastases in the course of illness.
Dainius ŠIMČIKAS   +4 more
doaj   +1 more source

Metastatic breast cancer patients with lung or liver metastases should be distinguished before being treated with fulvestrant

open access: yesCancer Medicine, 2019
Background Endocrine therapy is the preferred treatment for patients with hormone receptor ‐positive metastatic breast cancer (MBC). While visceral metastasis is a negative prognostic factor, few studies have distinguished between the prognoses of ...
Min He   +7 more
doaj   +1 more source

68Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer

open access: yesCancer Imaging, 2019
Background The purpose of this study was to evaluate the imaging properties of hepatic metastases in 68Ga-PSMA positron emission tomography (PET) in patients with prostate cancer (PC).
Jonathan Damjanovic   +6 more
doaj   +1 more source

The evolving role of radiation therapy as treatment for liver metastases

open access: yesJournal of the National Cancer Center, 2022
Liver metastases occur commonly in many solid malignancies. With advances in systemic therapies and increased life expectancy, the role of using local therapies in oligo-metastases is rapidly increasing.
Khalid Alrabiah   +4 more
doaj   +1 more source

PD-L1 expression in liver metastasis: its clinical significance and discordance with primary tumor in colorectal cancer

open access: yesJournal of Translational Medicine, 2020
Background The outcomes of immune checkpoint inhibitors in cancer patients with liver metastases are poor, which may be related to a different tumor microenvironment in liver metastases from primary tumors.
Xiao-Li Wei   +7 more
doaj   +1 more source

Mechanisms of drug resistance in breast cancer liver metastases: Dilemmas and opportunities

open access: yesMolecular Therapy: Oncolytics, 2023
Breast cancer is the leading cause of cancer-related deaths in females worldwide, and the liver is one of the most common sites of distant metastases in breast cancer patients.
Chun-Yan Yan   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy